Cytokinetics, Incorporated (NASDAQ: CYTK) announced that a poster summarizing non-clinical data from its smooth muscle contractility program was presented at the American Society of Hypertension 24th Annual Scientific Meeting and Exposition being held May 6 - May 9, 2009 in San Francisco, California. The authors concluded that direct inhibition of smooth muscle myosin may offer a novel therapeutic approach for the treatment (more…)

Fovea Pharmaceuticals announced positive results from its clinical proof-of-concept trial to assess the therapeutic effect of Prednisporin(TM) (FOV1101) in patients with persistent allergic conjunctivitis.
Prednisporin(TM) had the same efficacy and a better safety profile (no increase in intra-ocular pressure) than PredForte(TM), a prescription drug with a 10 fold higher dose of prednisolone acetate, in patients treated (more…)

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN) announced preliminary results for its sexual dysfunction drug candidate, Zoraxel™, from a Phase IIa clinical study for the treatment of erectile dysfunction (ED). The double blind, randomized, placebo-controlled, dose ranging study found that human subjects treated with Zoraxel demonstrated improved erectile function as measured (more…)

A simple, automated feedback system made hypertension patients more aware of their potentially fatal or disabling disease and helped them significantly lower their high blood pressure, according to a report published in Circulation: Cardiovascular Quality and Outcomes.
In a one-year study, the computer-based system telephoned participants at least once a week and a voice-recognition program asked for the most recent blood pressure (more…)

New research has revealed that dairy products such as low-fat milk may help to reduce risk of high blood pressure in older age.
It is estimated that one in three adults in the UK suffers from hypertension, yet only a third of individuals are aware of their condition.
High blood pressure is one of the most significant risk factors for stroke, heart attack, heart failure and kidney disease. The lack of immediately identifiable (more…)